Dabigatran>95.0%(HPLC)500mg

(2E)-3-(4-ethylphenyl)-1-(4-nitrophenyl)prop-2-en-1-one, 95.0%, 10g

5-Oxo-5-(4-trifluoromethylphenyl)valeric acid, 97.0%, 1g

3-Phenylpropanal, 97.0%, 5g

(1-Methyl-pyrrolidin-3-yloxy)-acetic acid, 10g

4-Bromo-3,5-diethoxybenzaldehyde, 98%, 25g

Benzyl 2-Aminobenzoate>98.0%(GC)(T)5g

1-(5-bromo-1H-indol-3-yl)-2-chloroethanone, 95.0%, 1g

(11bR)?-8,?9,?10,?11,?12,?13,?14,?15-Octahydro-?4-?hydroxy-?2,?6-?bis(4-?nitrophenyl)?-4-?oxide-dinaphtho[2,?1-?d:1',?2'-?f]?[1,?3,?2]?dioxaphosphepin, 97%, 250mg

1-(3-METHYL-1,2,4-THIADIAZOL-5-YL)-1,4-DIAZEPANE, 95%, 1g

2-Bromo-9-(2-ethylhexyl)-9H-carbazole>98.0%(GC)1g

Silica gel 60, 500 g

N-BOC-L-GLUTAMIC ACID DIMETHYL ESTER, 97.0%, 500g